This report provides a comprehensive analysis of the global Gene Expression and Transcriptome Sequencing market, projecting significant growth through 2032. It examines key market dynamics, including drivers and emerging opportunities across various product types and applications such as pharmaceutical research, academic institutions, and diagnostic centers. By evaluating regional trends in the Americas, APAC, and Europe, the study highlights the competitive landscape and strategic positioning of major industry players, including Thermo Fisher Scientific and Illumina.

Market Overview

Global Market Projections

The global Gene Expression and Transcriptome Sequencing market size is predicted to grow from US$ 5560 million in 2025 to US$ 12570 million in 2032, with an expected compound annual growth rate (CAGR) of 12.6% from 2026 to 2032.

Regional Market Projections

• United States: The market for Gene Expression and Transcriptome Sequencing is estimated to experience growth from 2025 through 2032.
• China: The market for Gene Expression and Transcriptome Sequencing is estimated to experience growth from 2025 through 2032.
• Europe: The market for Gene Expression and Transcriptome Sequencing is estimated to experience growth from 2025 through 2032.

Technical Background

Gene Expression Definition: Gene expression refers to the process by which information encoded in a gene is used to create functional gene products, such as proteins or non-coding RNAs. This process involves the transcription of DNA into RNA and the subsequent translation of RNA into proteins.

Biological Significance: Gene expression is a fundamental process that plays a crucial role in various biological processes, including development, growth, and the maintenance of tissues, as well as the response to environmental stimuli.

Report Scope and Methodology

Research Objectives

LPI (LP Information)' newest research report, the “Gene Expression and Transcriptome Sequencing Industry Forecast,” reviews total world Gene Expression and Transcriptome Sequencing sales in 2025. The report provides a comprehensive analysis by region and market sector of projected Gene Expression and Transcriptome Sequencing sales for the period from 2026 through 2032.

This Insight Report provides a comprehensive analysis of the global Gene Expression and Transcriptome Sequencing landscape and highlights key trends related to:

• Product segmentation
• Company formation
• Revenue and market share
• Latest developments
• M&A activity

The report also analyzes the strategies of leading global companies, focusing on Gene Expression and Transcriptome Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints to better understand these firms’ unique position in an accelerating global market.

Analytical Approach

The report evaluates key market trends, drivers, and affecting factors shaping the global outlook for Gene Expression and Transcriptome Sequencing. It breaks down the forecast by Type, Application, geography, and market size to highlight emerging pockets of opportunity. Using a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study offers a highly nuanced view of the current state and future trajectory of the global industry.

Detailed analysis is provided in US$ millions, with sales broken down by region, market sector, and sub-sector. The report presents a comprehensive overview, market shares, and growth opportunities by product type, application, key players, and key regions and countries.

Market Segmentation

By Type

• Gene Expression
• Transcriptome Sequencing

By Application

• Pharmaceutical and Biotechnology
• Academic Research and Government Institutes
• Hospitals and Diagnostic Centers

By Region

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Key Market Dynamics

Global key Gene Expression and Transcriptome Sequencing players include Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, and Roche. In terms of revenue, the global two largest companies occupied a significant portion of the market share in 2025.

Profiled Companies

The following companies have been profiled based on inputs gathered from primary experts and an analysis of the company's coverage, product portfolio, and market penetration:

• Thermo Fisher Scientific
• Illumina
• QIAGEN (Exiqon)
• Agilent Technologies
• Roche
• GE Healthcare
• Bio-Rad Laboratories
• Fluidigm

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Gene Expression and Transcriptome Sequencing Market Size (2021-2032)

    • 2.1.2 Gene Expression and Transcriptome Sequencing Market Size CAGR by Region (2021 VS 2025 VS 2032)

    • 2.1.3 World Current & Future Analysis for Gene Expression and Transcriptome Sequencing by Country/Region (2021, 2025 & 2032)

  • 2.2 Gene Expression and Transcriptome Sequencing Segment by Type

    • 2.2.1 Gene Expression

    • 2.2.2 Transcriptome Sequencing

    • 2.2.3 Gene Expression and Transcriptome Sequencing Market Size by Type

      • 2.2.3.1 Gene Expression and Transcriptome Sequencing Market Size CAGR by Type (2021 VS 2025 VS 2032)
      • 2.2.3.2 Global Gene Expression and Transcriptome Sequencing Market Size Market Share by Type (2021-2026)

  • 2.3 Gene Expression and Transcriptome Sequencing Segment by Application

    • 2.3.1 Pharmaceutical and Biotechnology

    • 2.3.2 Academic Research and Government Institutes

    • 2.3.3 Hospitals and Diagnostic Centers

    • 2.3.4 Gene Expression and Transcriptome Sequencing Market Size by Application

      • 2.3.4.1 Gene Expression and Transcriptome Sequencing Market Size CAGR by Application (2021 VS 2025 VS 2032)
      • 2.3.4.2 Global Gene Expression and Transcriptome Sequencing Market Size Market Share by Application (2021-2026)

• 3 Gene Expression and Transcriptome Sequencing Market Size by Player

  • 3.1 Gene Expression and Transcriptome Sequencing Market Size Market Share by Player

    • 3.1.1 Global Gene Expression and Transcriptome Sequencing Revenue by Player (2021-2026)

    • 3.1.2 Global Gene Expression and Transcriptome Sequencing Revenue Market Share by Player (2021-2026)

  • 3.2 Global Gene Expression and Transcriptome Sequencing Key Players Head office and Products Offered

  • 3.3 Market Concentration Rate Analysis

    • 3.3.1 Competition Landscape Analysis

    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.4 New Products and Potential Entrants

  • 3.5 Mergers & Acquisitions, Expansion

• 4 Gene Expression and Transcriptome Sequencing by Region

  • 4.1 Gene Expression and Transcriptome Sequencing Market Size by Region (2021-2026)

  • 4.2 Global Gene Expression and Transcriptome Sequencing Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Gene Expression and Transcriptome Sequencing Market Size Growth (2021-2026)

  • 4.4 APAC Gene Expression and Transcriptome Sequencing Market Size Growth (2021-2026)

  • 4.5 Europe Gene Expression and Transcriptome Sequencing Market Size Growth (2021-2026)

  • 4.6 Middle East & Africa Gene Expression and Transcriptome Sequencing Market Size Growth (2021-2026)

• 5 Americas

  • 5.1 Americas Gene Expression and Transcriptome Sequencing Market Size by Country (2021-2026)

  • 5.2 Americas Gene Expression and Transcriptome Sequencing Market Size by Type (2021-2026)

  • 5.3 Americas Gene Expression and Transcriptome Sequencing Market Size by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Gene Expression and Transcriptome Sequencing Market Size by Region (2021-2026)

  • 6.2 APAC Gene Expression and Transcriptome Sequencing Market Size by Type (2021-2026)

  • 6.3 APAC Gene Expression and Transcriptome Sequencing Market Size by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

• 7 Europe

  • 7.1 Europe Gene Expression and Transcriptome Sequencing Market Size by Country (2021-2026)

  • 7.2 Europe Gene Expression and Transcriptome Sequencing Market Size by Type (2021-2026)

  • 7.3 Europe Gene Expression and Transcriptome Sequencing Market Size by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Gene Expression and Transcriptome Sequencing by Region (2021-2026)

  • 8.2 Middle East & Africa Gene Expression and Transcriptome Sequencing Market Size by Type (2021-2026)

  • 8.3 Middle East & Africa Gene Expression and Transcriptome Sequencing Market Size by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Global Gene Expression and Transcriptome Sequencing Market Forecast

  • 10.1 Global Gene Expression and Transcriptome Sequencing Forecast by Region (2027-2032)

    • 10.1.1 Global Gene Expression and Transcriptome Sequencing Forecast by Region (2027-2032)

    • 10.1.2 Americas Gene Expression and Transcriptome Sequencing Forecast

    • 10.1.3 APAC Gene Expression and Transcriptome Sequencing Forecast

    • 10.1.4 Europe Gene Expression and Transcriptome Sequencing Forecast

    • 10.1.5 Middle East & Africa Gene Expression and Transcriptome Sequencing Forecast

  • 10.2 Americas Gene Expression and Transcriptome Sequencing Forecast by Country (2027-2032)

    • 10.2.1 United States Market Gene Expression and Transcriptome Sequencing Forecast

    • 10.2.2 Canada Market Gene Expression and Transcriptome Sequencing Forecast

    • 10.2.3 Mexico Market Gene Expression and Transcriptome Sequencing Forecast

    • 10.2.4 Brazil Market Gene Expression and Transcriptome Sequencing Forecast

  • 10.3 APAC Gene Expression and Transcriptome Sequencing Forecast by Region (2027-2032)

    • 10.3.1 China Gene Expression and Transcriptome Sequencing Market Forecast

    • 10.3.2 Japan Market Gene Expression and Transcriptome Sequencing Forecast

    • 10.3.3 Korea Market Gene Expression and Transcriptome Sequencing Forecast

    • 10.3.4 Southeast Asia Market Gene Expression and Transcriptome Sequencing Forecast

    • 10.3.5 India Market Gene Expression and Transcriptome Sequencing Forecast

    • 10.3.6 Australia Market Gene Expression and Transcriptome Sequencing Forecast

  • 10.4 Europe Gene Expression and Transcriptome Sequencing Forecast by Country (2027-2032)

    • 10.4.1 Germany Market Gene Expression and Transcriptome Sequencing Forecast

    • 10.4.2 France Market Gene Expression and Transcriptome Sequencing Forecast

    • 10.4.3 UK Market Gene Expression and Transcriptome Sequencing Forecast

    • 10.4.4 Italy Market Gene Expression and Transcriptome Sequencing Forecast

    • 10.4.5 Russia Market Gene Expression and Transcriptome Sequencing Forecast

  • 10.5 Middle East & Africa Gene Expression and Transcriptome Sequencing Forecast by Region (2027-2032)

    • 10.5.1 Egypt Market Gene Expression and Transcriptome Sequencing Forecast

    • 10.5.2 South Africa Market Gene Expression and Transcriptome Sequencing Forecast

    • 10.5.3 Israel Market Gene Expression and Transcriptome Sequencing Forecast

    • 10.5.4 Turkey Market Gene Expression and Transcriptome Sequencing Forecast

  • 10.6 Global Gene Expression and Transcriptome Sequencing Forecast by Type (2027-2032)

  • 10.7 Global Gene Expression and Transcriptome Sequencing Forecast by Application (2027-2032)

    • 10.7.1 GCC Countries Market Gene Expression and Transcriptome Sequencing Forecast

• 11 Key Players Analysis

  • 11.1 Thermo Fisher Scientific

    • 11.1.1 Thermo Fisher Scientific Company Information

    • 11.1.2 Thermo Fisher Scientific Gene Expression and Transcriptome Sequencing Product Offered

    • 11.1.3 Thermo Fisher Scientific Gene Expression and Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)

    • 11.1.4 Thermo Fisher Scientific Main Business Overview

    • 11.1.5 Thermo Fisher Scientific Latest Developments

  • 11.2 Illumina

    • 11.2.1 Illumina Company Information

    • 11.2.2 Illumina Gene Expression and Transcriptome Sequencing Product Offered

    • 11.2.3 Illumina Gene Expression and Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)

    • 11.2.4 Illumina Main Business Overview

    • 11.2.5 Illumina Latest Developments

  • 11.3 QIAGEN (Exiqon)

    • 11.3.1 QIAGEN (Exiqon) Company Information

    • 11.3.2 QIAGEN (Exiqon) Gene Expression and Transcriptome Sequencing Product Offered

    • 11.3.3 QIAGEN (Exiqon) Gene Expression and Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)

    • 11.3.4 QIAGEN (Exiqon) Main Business Overview

    • 11.3.5 QIAGEN (Exiqon) Latest Developments

  • 11.4 Agilent Technologies

    • 11.4.1 Agilent Technologies Company Information

    • 11.4.2 Agilent Technologies Gene Expression and Transcriptome Sequencing Product Offered

    • 11.4.3 Agilent Technologies Gene Expression and Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)

    • 11.4.4 Agilent Technologies Main Business Overview

    • 11.4.5 Agilent Technologies Latest Developments

  • 11.5 Roche

    • 11.5.1 Roche Company Information

    • 11.5.2 Roche Gene Expression and Transcriptome Sequencing Product Offered

    • 11.5.3 Roche Gene Expression and Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)

    • 11.5.4 Roche Main Business Overview

    • 11.5.5 Roche Latest Developments

  • 11.6 GE Healthcare

    • 11.6.1 GE Healthcare Company Information

    • 11.6.2 GE Healthcare Gene Expression and Transcriptome Sequencing Product Offered

    • 11.6.3 GE Healthcare Gene Expression and Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)

    • 11.6.4 GE Healthcare Main Business Overview

    • 11.6.5 GE Healthcare Latest Developments

  • 11.7 Bio-Rad Laboratories

    • 11.7.1 Bio-Rad Laboratories Company Information

    • 11.7.2 Bio-Rad Laboratories Gene Expression and Transcriptome Sequencing Product Offered

    • 11.7.3 Bio-Rad Laboratories Gene Expression and Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)

    • 11.7.4 Bio-Rad Laboratories Main Business Overview

    • 11.7.5 Bio-Rad Laboratories Latest Developments

  • 11.8 Fluidigm

    • 11.8.1 Fluidigm Company Information

    • 11.8.2 Fluidigm Gene Expression and Transcriptome Sequencing Product Offered

    • 11.8.3 Fluidigm Gene Expression and Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)

    • 11.8.4 Fluidigm Main Business Overview

    • 11.8.5 Fluidigm Latest Developments

• 12 Research Findings and Conclusion